The recent pandemic prevalence of obesity, not only in adults but also in children, together with the rising awareness of the burden of this condition on population health and health costs, have considerably contributed to intensify our efforts to understand obesity, which is now at the forefront of biochemical, biomolecular and neurobiological research.In morbidly obese subjects, physiological disturbances are amplified and their extreme manifestations are more easily measured. The significant and predictable effects of bariatric surgery present a striking contrast to preoperative morbid conditions. Bariatric surgery in humans offers a window of opportunity to further understand obesity and associated diseases.Bariatric/metabolic surgeries are being performed increasingly in response to the epidemic of obesity. Their widespread acceptance stems in part from their remarkable success in reducing weight over a sustained period of time, and for having marked metabolic effects on glucose homeostasis, essentially curing Type 2 diabetes in as many as 80% of patients following surgery. In fact, the metabolic benefits of these surgeries often occur before significant weight loss, and their magnitude is far greater than can be explained by the loss of weight alone. This accounts for their long-term benefits and low rates of recidivism. Given these findings, it is perhaps not surprising that one of the big unanswered questions in obesity research is how does bariatric/metabolic surgery work? Establishing these mechanisms will offer new insights into the physiology of energy balance and the control of metabolism.The Merck Frosst/CIHR Research Chair held in October 2010 its 13 th Annual International Symposium, which focused on mechanisms whereby bariatric/metabolic surgery influences energy balance regulation. The meeting was divided into two sessions and involved eight speakers among the most renowned researchers in the field of bariatric surgery. Karine Clément (Paris), who had the task of speaking on morbid obesity and the pathophysiology of obesity, stressed the importance of the gene-environment interaction in the development of massive obesity. Philip Schauer (Cleveland) presented a comprehensive description of the various procedures used in bariatric surgery. Blandine Laferrère (New York) reported on the major role of incretins in diabetes remission after bariatric surgery. Paul R. Burton (Melbourne) made a comprehensive exposé on laparoscopic adjustable gastric banding. Carel Leroux (London) emphasized the stimulating effects of the Roux-en-Y gastric bypass on energy expenditure. Hans Berthoud (Baton Rouge) summarized the effects of the Roux-en-Y gastric bypass on the functions of food reward. Darleen Sandoval (Cincinnati) focused on the metabolic effects of the vertical sleeve gastrectomy. Finally, Lee Kaplan (Boston) presented his latest results obtained in his mouse model of Roux-en-Y gastric bypass, demonstrating the positive effects of the surgery on brown adipose tissue thermogenesis.Altogether, the speakers ...